A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients

NCT03502681 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class

Stopped Funder Decision

Conditions

Interventions

Sponsor

Monika Joshi, MD

Collaborators